318 related articles for article (PubMed ID: 29872892)
1. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision.
Rowley MW; Choi M; Chen S; Hirsch K; Seetharam AB
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1765-1772. PubMed ID: 29872892
[TBL] [Abstract][Full Text] [Related]
2. Endovascular Management of Refractory Hepatic Encephalopathy Complication of Transjugular Intrahepatic Portosystemic Shunt (TIPS): Comprehensive Review and Clinical Practice Algorithm.
Pereira K; Carrion AF; Salsamendi J; Doshi M; Baker R; Kably I
Cardiovasc Intervent Radiol; 2016 Feb; 39(2):170-82. PubMed ID: 26285910
[TBL] [Abstract][Full Text] [Related]
3. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
[TBL] [Abstract][Full Text] [Related]
4. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
5. Reversal of transjugular intrahepatic portosystemic shunt (TIPS)-induced hepatic encephalopathy using a strictured self-expanding covered stent.
Cox MW; Lin PH; Bush RL; Lumsden AB
Cardiovasc Intervent Radiol; 2003; 26(6):539-42. PubMed ID: 15061178
[TBL] [Abstract][Full Text] [Related]
6. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
7. Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
Riggio O; Angeloni S; Salvatori FM; De Santis A; Cerini F; Farcomeni A; Attili AF; Merli M
Am J Gastroenterol; 2008 Nov; 103(11):2738-46. PubMed ID: 18775022
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.
Fonio P; Discalzi A; Calandri M; Doriguzzi Breatta A; Bergamasco L; Martini S; Ottobrelli A; Righi D; Gandini G
Radiol Med; 2017 Sep; 122(9):713-721. PubMed ID: 28510807
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.
Yao J; Zuo L; An G; Yue Z; Zhao H; Wang L; Liu F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):301-7. PubMed ID: 26405702
[TBL] [Abstract][Full Text] [Related]
10. History of Hepatic Encephalopathy Is Not a Contraindication to Transjugular Intrahepatic Portosystemic Shunt Placement for Refractory Ascites.
Saab S; Zhao M; Asokan I; Yum JJ; Lee EW
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00378. PubMed ID: 34333500
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt Reduction for Overshunting Adverse Events.
Shah RJ; Alqadi MM; Duvvuri M; Kim YJ; Tyagi R; Lokken RP; Gaba RC
J Vasc Interv Radiol; 2022 Dec; 33(12):1507-1512. PubMed ID: 35964879
[TBL] [Abstract][Full Text] [Related]
13. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
[TBL] [Abstract][Full Text] [Related]
14. Transjugular Portosystemic Shunt Reductions: A Retrospective Single-Center Experience.
Joseph AS; Sandhu B; Khalil A; Lopera J
J Vasc Interv Radiol; 2019 Jun; 30(6):876-884. PubMed ID: 31126600
[TBL] [Abstract][Full Text] [Related]
15. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
16. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of albumin-bilirubin score to predict hepatic encephalopathy in patients underwent transjugular intrahepatic portosystemic shunt.
Lin X; Gao F; Wu X; Cai W; Chen X; Huang Z
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):862-871. PubMed ID: 32541240
[TBL] [Abstract][Full Text] [Related]
18. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
19. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
20. Pathological Predictors of Shunt Stenosis and Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt.
He F; Dai S; Xiao Z; Wang L; Yue Z; Zhao H; Zhao M; Lin Q; Dong X; Liu F
Biomed Res Int; 2016; 2016():3681731. PubMed ID: 27975051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
